Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

CDSCO, State Drugs Control Administration begin joint inspection of drug manufacturing units

Ruchika Sharma28 Dec 2022 1:30 PM IST

An action plan for nationwide inspection of manufacturing units which are identified to be at risk of manufacturing Not of Standard Quality...

Gilead Sciences to acquire all remaining rights to potential first-in-class immunotherapy GS-1811 from Jounce Therapeutics

Ruchika Sharma28 Dec 2022 12:30 PM IST

Jounce will receive proceeds of $67 million for this transaction, and Gilead will be solely responsible for all further research, development, and...

AstraZeneca to Invest USD 15 Billion in China by 2030

AstraZeneca gets Japanese approval for Imfinzi, Imjudo to treat 3 types of cancer

Ruchika Sharma28 Dec 2022 11:30 AM IST

Imfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...

Cipla expects elevated capital expenditure on automation to continue for three more years

Ruchika Sharma27 Dec 2022 5:31 PM IST

Mumbai: Cipla expects elevated capital expenditure on automation to continue for three more years, a senior official has said. The city-headquartered...

Aurobindo Pharma arm Rajasthan facility gets 9 USFDA observations

Aurobindo Pharma JV Tergene gets CDSCO panel recommendation for 15-valent Pneumococcal Polysaccharide Conjugate Vaccine

Ruchika Sharma27 Dec 2022 3:42 PM IST

Hyderabad: Drugmaker, Aurobindo Pharma Ltd, has announced that Subject Expert Committee (SEC) of the Central Drugs StandardControl Organization...

COVID intranasal vaccine: Bharat Biotech iNCOVACC priced at Rs 800 for private hospitals, Rs 325 for Govt

Ruchika Sharma27 Dec 2022 2:30 PM IST

iNCOVACC is the world's first intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose.

BioNTech, Fosun Pharma get full regulatory approval for COMIRNATY in individuals 12 years and older in Hong Kong

Ruchika Sharma27 Dec 2022 1:30 PM IST

Shanghai: BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. have announced that the Fosun Industrial Co., Limited (as a...

Lupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli Ulcer

Hikma Pharma, Junshi Biosciences ink pact for Cancer drug Toripalimab commercialisation in Middle East, North Africa

Ruchika Sharma27 Dec 2022 12:20 PM IST

As part of this collaboration, Hikma has acquired rights to commercialize any combination product that comprises any therapeutically active...

AP: Fire at Laurus Pharma labs Parawada unit, 4 killed and 1 injured

Ruchika Sharma27 Dec 2022 11:15 AM IST

Amarnath informed that the Chief Minister announced that compensation of Rs 25 lakh will be paid to the families of the deceased workers.

WHO plans to back use of weight-loss drugs for adults globally

FIRST: Hetero wins WHO Prequalification for generic version of Pfizer COVID drug Paxlovid

Ruchika Sharma26 Dec 2022 4:15 PM IST

The combi pack, launched by Hetero as NIRMACOM, will contain nirmatrelvir 150 mg (2 tablets) and ritonavir 100mg (1 tablet).

Sanofi to buy Vigil Neuroscience in USD 470 million deal

Advent International to purchase significant stake in Suven Pharma, plans merger with Cohance Lifesciences

Ruchika Sharma26 Dec 2022 3:15 PM IST

As part of the transaction, Advent will also be making an open offer to acquire an additional 26% of the outstanding equity shares of the company from...

USFDA nod to JnJ Tremfya for Crohns disease

Abiomed now part of Johnson and Johnson

Ruchika Sharma26 Dec 2022 2:15 PM IST

New Brunswick: Johnson & Johnson has announced that the company has completed its acquisition of Abiomed, Inc. is now part of Johnson &...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok